was read the article
array:23 [ "pii" => "S2387020622003874" "issn" => "23870206" "doi" => "10.1016/j.medcle.2022.03.012" "estado" => "S300" "fechaPublicacion" => "2022-09-09" "aid" => "5981" "copyright" => "Elsevier España, S.L.U.. All rights reserved" "copyrightAnyo" => "2022" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2022;159:e33-e34" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:19 [ "pii" => "S2387020622004053" "issn" => "23870206" "doi" => "10.1016/j.medcle.2022.08.004" "estado" => "S300" "fechaPublicacion" => "2022-09-09" "aid" => "5984" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2022;159:e35-e36" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Dilated cardiomyopathy secondary to methamphetamine intoxication (Shabu)" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "e35" "paginaFinal" => "e36" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Miocardiopatía dilatada secundaria a intoxicación por metanfetaminas (shabú)" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "María Carrera-Morodo, Adrián Fernández Sánchez, José Cristóbal Díaz Villanueva" "autores" => array:3 [ 0 => array:2 [ "nombre" => "María" "apellidos" => "Carrera-Morodo" ] 1 => array:2 [ "nombre" => "Adrián" "apellidos" => "Fernández Sánchez" ] 2 => array:2 [ "nombre" => "José Cristóbal" "apellidos" => "Díaz Villanueva" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0025775322002391" "doi" => "10.1016/j.medcli.2022.03.021" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775322002391?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020622004053?idApp=UINPBA00004N" "url" => "/23870206/0000015900000005/v1_202209020725/S2387020622004053/v1_202209020725/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2387020622003813" "issn" => "23870206" "doi" => "10.1016/j.medcle.2022.02.025" "estado" => "S300" "fechaPublicacion" => "2022-09-09" "aid" => "5948" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2022;159:e32" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Healing of chronic hepatitis delta relapsing to pegylated interferon with tenofovir" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "e32" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Curación con tenofovir de la hepatitis crónica delta recidivante al interferón pegilado" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Alberto Ezquerra-Durán, Ainhoa Gutiérrez-Cobos, Luisa García-Buey" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Alberto" "apellidos" => "Ezquerra-Durán" ] 1 => array:2 [ "nombre" => "Ainhoa" "apellidos" => "Gutiérrez-Cobos" ] 2 => array:2 [ "nombre" => "Luisa" "apellidos" => "García-Buey" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S002577532200152X" "doi" => "10.1016/j.medcli.2022.02.017" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S002577532200152X?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020622003813?idApp=UINPBA00004N" "url" => "/23870206/0000015900000005/v1_202209020725/S2387020622003813/v1_202209020725/en/main.assets" ] "en" => array:14 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Useful tools in post-COVID syndrome evaluation" "tieneTextoCompleto" => true "saludo" => "Dear Editor:" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "e33" "paginaFinal" => "e34" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Blanca Ayuso García, Eva Romay Lema, Ramón Rabuñal Rey" "autores" => array:3 [ 0 => array:4 [ "nombre" => "Blanca" "apellidos" => "Ayuso García" "email" => array:1 [ 0 => "blanca.ayuso90@gmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "Eva" "apellidos" => "Romay Lema" ] 2 => array:2 [ "nombre" => "Ramón" "apellidos" => "Rabuñal Rey" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Infectious Diseases Unit, University Hospital Lucus Augusti, Lugo, Spain" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Escalas de utilidad para la evaluación del síndrome post-COVID" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">We have read with interest the article by Boix et al.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">1</span></a> in which they put the focus on the need for a precise definition of post-COVID syndrome enabling an adequate care of patients who need it.</p><p id="par0010" class="elsevierStylePara elsevierViewall">Our team also felt the necessity to assess and quantify the dimension of this syndrome, in order to stratify the impact and healthcare needs of patients. To that end, we administered a telephone survey with two scales, EuroQoL 5D-5L and C19-YRS, to patients infected with SARS-CoV-2 during the first pandemic wave, 10 months after the acute infection (November 2020–February 2021). EuroQol 5D-5L is a validated tool for the assessment of health-related quality of life, which has its population data available for consultation, thus making it possible to compare samples against the baseline status.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">2</span></a> C19-YRS was developed in 2020 specifically to evaluate symptoms after acute COVID-19, and also explores the job status and caregiver role of individuals.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">3</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">All ambulatory and hospitalized patients with a positive molecular diagnostic test were included.<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">4</span></a> From 745 infected people, 44 died and 93 had dementia and were excluded since information could not be retrieved; a total of 443 answers were obtained (answer rate 72.9%). Mean age was 54<span class="elsevierStyleHsp" style=""></span>+/−<span class="elsevierStyleHsp" style=""></span>16 years, 38.4% of patients were male, and 42.9% of them had some prior condition. The hospitalization rate was 19.6% and 2.3% of patients required admission to an ICU.</p><p id="par0020" class="elsevierStylePara elsevierViewall">Differences were found when comparing the results of both tools. Some symptom was reported by 36.8% of patients using EQ-5D-5L, while 63.2% of patients had some complaint according to C19-YRS. The domains with a higher proportion of impairment in EQ-5D-5L were anxiety/depression (23.9%) and mobility (16.5%), whereas in C19-YRS fatigue (23.0%) and exercise breathlessness (17.2%) were the most affected.</p><p id="par0025" class="elsevierStylePara elsevierViewall">When the items shared by the two tools were compared, similar rates of impairment where observed, perhaps subtly higher when EQ-5D-5L was used. Global symptom detection was higher using C19-YRS, probably due to a higher number of items being explored. This is however difficult to interpret, since a higher number of symptoms does not necessarily imply a worse quality of life with respect to the same population before the infection.</p><p id="par0030" class="elsevierStylePara elsevierViewall">A good agreement was found in the evaluation of mobility, self-care and anxiety/depression, which was only moderate in basic activities of daily living and pain/discomfort (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). Diverging scores were found in severity grading for each item, which were higher in the domain of pain/discomfort. This could be explained regarding the highly subjective experience of pain.</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0035" class="elsevierStylePara elsevierViewall">C19-YRS has some additional advantages like the assessment of work status impairment after SARS-CoV-2 infection. In our sample, 8.9% of patients were on a medical leave when they were interviewed, 3.5% were unemployed, and 7.7% reported difficulties performing the usual tasks at work, results in agreement with what Boix et al. remark in terms of inability of returning to working life.<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">5</span></a> Meanwhile, EQ-5D-5L overall scores are similar to the scores of the same population before the pandemic, which opposes a worsening in current self-health perception.<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">4</span></a></p><p id="par0040" class="elsevierStylePara elsevierViewall">In conclusion, a proper selection of tools which allow for screening and comparing the impact of post-COVID syndrome is critical through the development and enforcement of post-COVID programs. Agreement between the featured scales is in general terms moderate to good and both, although probably not exchangeable, can be used to assess and establish comparisons in results. More, wider studies are needed to definitely choose one over the several others in the evaluation of post-COVID patients.</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Funding</span><p id="par0045" class="elsevierStylePara elsevierViewall">No funding was perceived by the authors.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Funding" ] 1 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "multimedia" => array:1 [ 0 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:1 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">EQ-5D-5L \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">C19-YRS \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Kappa (% agreement) \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">p</span>-value \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Mobility \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">73 (16.5%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">45 (10.2%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.681 (83.5) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><0.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Self-care \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">10 (2.3%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">4 (0.9%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.763 (98.6) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><0.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">BADL \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">52 (11.7%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">60 (13.5%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.597 (88.7) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><0.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Pain \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">59 (13.3%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">75 (16.9%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.601 (87.4) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><0.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Anxiety/depression \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">106 (23.6%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">71 (16.0%)/63 (14.2%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.724 (88.3) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><0.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Rates of impairment and agreement between EQ-5D-5L and C19-YRS in shared domains.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:5 [ 0 => array:3 [ "identificador" => "bib0030" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Post-COVID syndrome. The never ending challenge" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "V. Boix" 1 => "E. Merino" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.medcle.2021.10.005" "Revista" => array:5 [ "tituloSerie" => "Med Clin (Barc)" "fecha" => "2022" "volumen" => "158" "paginaInicial" => "178" "paginaFinal" => "180" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0035" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "EQ-5D-5L user guide" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "EuroQol Research Foundation" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:1 [ "fecha" => "2019" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0040" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Assessing long-term rehabilitation needs in COVID-19 survivors using a telephone screening tool (C19-YRS tool)" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "M. Sivan" 1 => "S. Halpin" 2 => "J. Gee" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:2 [ "tituloSerie" => "Adv Clin Neurosci Rehabil" "fecha" => "2020" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0045" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Calidad de vida relacionada con la salud en pacientes recuperados de COVID-19" "tituloTraducido" => "Health-related quality of life in patients recovered from COVID-19" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "B. Ayuso García" 1 => "A. Pérez López" 2 => "Y. Besteiro Balado" 3 => "E. Romay Lema" 4 => "M.J. García País" 5 => "Á. Marchán-López" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jhqr.2022.01.001" "Revista" => array:2 [ "tituloSerie" => "J Healthc Qual Res" "fecha" => "2022" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0050" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Síndrome post-COVID: un documento de reflexión y opinión" "tituloTraducido" => "Post-COVID syndrome: a reflection and opinion paper" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "E. Bouza" 1 => "R. Cantón Moreno" 2 => "P. De Lucas Ramos" 3 => "A. García-Botella" 4 => "A. García-Lledó" 5 => "J. Gómez-Pavón" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.37201/req/023.2021" "Revista" => array:6 [ "tituloSerie" => "Rev Esp Quimioter" "fecha" => "2021" "volumen" => "34" "paginaInicial" => "269" "paginaFinal" => "279" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33878844" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/23870206/0000015900000005/v1_202209020725/S2387020622003874/v1_202209020725/en/main.assets" "Apartado" => array:4 [ "identificador" => "43309" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/23870206/0000015900000005/v1_202209020725/S2387020622003874/v1_202209020725/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020622003874?idApp=UINPBA00004N" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 October | 1 | 0 | 1 |
2024 September | 1 | 0 | 1 |
2024 August | 2 | 0 | 2 |
2024 July | 6 | 0 | 6 |
2024 June | 2 | 0 | 2 |
2024 May | 5 | 0 | 5 |
2024 April | 3 | 0 | 3 |
2024 March | 1 | 0 | 1 |
2024 February | 4 | 2 | 6 |
2024 January | 4 | 0 | 4 |
2023 December | 1 | 0 | 1 |
2023 March | 2 | 2 | 4 |